Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans

scientific article published on 5 February 2007

Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.01182-06
P932PMC publication ID1865729
P698PubMed publication ID17283095

P50authorKenneth W NickersonQ101047443
P2093author name stringJacob M Hornby
Navasona Krishnan
Gerald E Duhamel
Dhammika H M L P Navarathna
Anne Parkhurst
P2860cites workThe LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiaeQ27934767
Isolation and characterization of the Saccharomyces cerevisiae DPP1 gene encoding diacylglycerol pyrophosphate phosphatase.Q27935613
Nonfilamentous C. albicans mutants are avirulentQ29617839
Acquisition, transport, and storage of iron by pathogenic fungiQ33558328
Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicityQ33693878
Regulatory networks controlling Candida albicans morphogenesisQ33702252
Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicansQ33859372
Adherence of Candida albicans and other Candida species to mucosal epithelial cellsQ33899939
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitisQ34002848
Adherence of platelets to Candida species in vivoQ34003203
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent miceQ34008664
Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistanceQ34097610
Enhanced production of farnesol by Candida albicans treated with four azolesQ34142059
Virulence genes in the pathogenic yeast Candida albicansQ34183709
Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B.Q35102502
Candida albicans secreted aspartyl proteinases in virulence and pathogenesisQ35215948
Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicansQ35289673
Alternative Candida albicans lifestyles: growth on surfacesQ36253562
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infectionQ36370514
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatusQ36482511
Quorum sensing in dimorphic fungi: farnesol and beyondQ36496583
Roles of metallic ions in host-parasite interactionsQ37195362
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.Q39491534
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing moleculeQ39661623
Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicansQ39758862
Isolation and characterization of the Saccharomyces cerevisiae LPP1 gene encoding a Mg2+-independent phosphatidate phosphatase.Q42060536
Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detectionQ42547262
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicansQ42683173
Evidence for a correlation between proteinase secretion and vulvovaginal candidosisQ43868803
Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogsQ44572465
A comparison of phospholipase activity, cellular adherence and pathogenicity of yeastsQ44836869
Biologically active fluorescent farnesol analogsQ46564016
Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal hostQ46611821
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasisQ46765883
Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4pQ48046730
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homologQ48077116
The SAT1 flipper, an optimized tool for gene disruption in Candida albicansQ48168925
High-frequency switching in Candida albicans and its relations to vaginal candidiasis.Q54386066
Predominant pathogens in hospital infectionsQ54680963
The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutantQ68540124
Farnesol, psychosedative and spasmolytic drugQ68772075
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesolQ73182577
Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfite by species of CandidaQ73206023
In vitro synergistic effect of farnesol and human gingival cells against Candida albicansQ79918718
Iron-source preference of Staphylococcus aureus infectionsQ80551515
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectCandida albicansQ310443
candidiasisQ273510
P304page(s)1609-1618
P577publication date2007-02-05
P1433published inInfection and ImmunityQ6029193
P1476titleEffect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans
P478volume75

Reverse relations

cites work (P2860)
Q40541740A functional link between hyphal maintenance and quorum sensing in Candida albicans
Q41991036Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions
Q92071832Anticandidal Activity of Kalopanaxsaponin A: Effect on Proliferation, Cell Morphology, and Key Virulence Attributes of Candida albicans
Q34088663Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans
Q41875229Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis.
Q34467917Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity.
Q39888288Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7.
Q34103520Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans
Q35648733CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis
Q58838308Candida Urinary Tract Infection: Pathogenesis
Q34844550Candida albicans Czf1 and Efg1 coordinate the response to farnesol during quorum sensing, white-opaque thermal dimorphism, and cell death.
Q36160477Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis
Q27317563Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis
Q36053516Candida albicans Quorum Sensing Molecules Stimulate Mouse Macrophage Migration
Q36746973Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction
Q34188778Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expression
Q33351140Candida and invasive candidiasis: back to basics.
Q39490081Candida biofilms and the host: models and new concepts for eradication
Q37699331Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs
Q37648725Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans
Q35915352Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades.
Q51253744Deciphering fungal dimorphism: Farnesol's unanswered questions.
Q92479050Effect of Shikonin Against Candida albicans Biofilms
Q46702429Effect of Trans, Trans-Farnesol on Pseudogymnoascus destructans and Several Closely Related Species
Q36785890Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii.
Q35949651Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model
Q36362359Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans
Q35535689Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin
Q39369560Farnesol signalling in Candida albicans - more than just communication
Q36422270From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Q92219139Fungal Quorum-Sensing Molecules and Inhibitors with Potential Antifungal Activity: A Review
Q38773057Fungal quorum sensing molecules: Role in fungal morphogenesis and pathogenicity
Q37548161Host-pathogen interaction and signaling molecule secretion are modified in the dpp3 knockout mutant of Candida lusitaniae
Q35152853In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
Q64120011Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Pathogens
Q39978770Lipid signaling in pathogenic fungi
Q30542941MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis
Q51364123Mechanisms of interaction between Candida albicans and Streptococcus mutans: an experimental and mathematical modelling study.
Q28483683MicroRNA regulation of human protease genes essential for influenza virus replication
Q34189952Modulation of morphogenesis in Candida albicans by various small molecules
Q33379249Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans
Q46573245Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis
Q33369708Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans
Q42763564Quorum sensing and Bacterial Pathogenicity: From Molecules to Disease
Q39155578Quorum sensing by farnesol revisited
Q46352700Quorum sensing in Candida albicans: farnesol versus farnesoic acid
Q37977983Quorum sensing in fungi--a review
Q34358699Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production
Q40113973Study of trans-trans farnesol effect on hyphae formation by Yarrowia lipolytica.
Q38683382Systematic review of the in vitro effects of statins on oral and perioral microorganisms
Q41199859The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity
Q39233357The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
Q58430830Transcriptional Response of Candida parapsilosis following Exposure to Farnesol
Q35879037Transcriptional response of Candida parapsilosis following exposure to farnesol
Q28484600Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans
Q38955918Zap1 control of cell-cell signaling in Candida albicans biofilms